U.S. Market
Stocks were mixed today after earnings.

Greece was in focus again today. After initial signs that negotiations between Greece and its creditors were going nowhere, reports emerged midday that some progress was being made. Yields on U.S. bonds reversed gains on those reports.

At market close the Dow was off 0.5%, the S&P 500 was down 0.2% while the Nasdaq was up 0.4%.

Stocks on the Move
Teva (TEVA) has made an offer to buy generic drug rival Mylan (MYL) for $40 billion in cash and stock. Mylan did not comment on the bid, but has previously indicated it was not interested in a tie up and would prefer to remain independent. Shares of Mylan were up over 8% at market close while Teva shares rose over 1.5%.

DuPont's (DD) agriculture business continued to see pressure from a shift in North America from corn to soybeans. Despite volume pressure in both seeds and crop chemicals, DuPont was able to increase segment pricing 3% year over year, partially driven by improved mix of Pioneer's newest hybrids and varieties. Outside agriculture, DuPont's results were mixed. The titanium dioxide business performed worse than we expected, with volume dropping 12% and price down 7% year over year. DuPont is still on track to spin off the performance chemical segment, which houses titanium dioxide, in July. Shares were off nearly 3% at market close.

Verizon's (VZ) performance overall remained solid during the first quarter despite continued intense wireless competitive pressure. The competitive environment is most noticeable in the growth of average revenue per customer, which continues to slow despite massive increases in wireless data consumption. Offsetting this pressure, Verizon customer loyalty remains exceptionally strong, which is a significant component of its industry-best profitability. Shares were off less than 1% on the report.